title: Hematopoietic cell transplantation for lymphomas.
abstract: BACKGROUND
  The heterogeneity of lymphomas results in numerous treatment options, including both autologous and allogeneic hematopoietic cell transplantation. However, the type of transplantation, the timing the procedure, and the selection of suitable patients for transplant continue to evolve.
  
  
  METHODS
  We reviewed the current medical literature to provide a succinct synthesis for the most common types of lymphoma and the indications for transplantation.
  
  
  RESULTS
  This review discusses the outcomes of autologous and allogeneic transplantation for patients with diffuse large B-cell lymphoma, follicular lymphoma, HIV-associated lymphomas, mantle cell lymphoma, T-cell lymphoma, and Hodgkin lymphoma.
  
  
  CONCLUSIONS
  Each of these histologies differs in the indications and timing for transplantation. However, ongoing clinical trials support the continuing role of both autologous and allogeneic transplantation for lymphoma management.
authors: Blood and Marrow Transplant Program, Moffitt Cancer Center, Tampa, FL 33612, USA. Ernesto.Ayala@moffitt.org
authors: Ernesto
authors: E
authors: Ayala
authors: Marcie
authors: M
authors: Tomblyn
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008223:Lymphoma / Q000145:classification / Q000628:therapy*; D016019:Survival Analysis; D019172:Transplantation Conditioning / Q000379:methods; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D016896:Treatment Outcome